RemeGen Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by RemeGen Co., Ltd.
RECRUITINGPhase 1 / Phase 2NCT06378242
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients...
The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of intravesical instiliations of Disitamab Vedotin in patients with high-risk non-muscular...
Sponsor: RemeGen Co., Ltd.Enrolling: 246 locations
High-risk Non-muscle Invasive Bladder Cancer
RECRUITINGPhase 2NCT05680480
A Study of Telitacicept in Lupus Nephritis
The purpose of this study is to evaluate the safety and efficacy of Telitacicept in adult patients with active lupus nephritis.
Sponsor: RemeGen Co., Ltd.Enrolling: 12020 locations
Lupus Nephritis
RECRUITINGPhase 3NCT07249632
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
This is a Phase III, multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Telitacicept for the treatment of Ocular...
Sponsor: RemeGen Co., Ltd.Enrolling: 1201 location
Myasthenia Gravis, Ocular